Skip to main content
HairCited

Viviscal for Telogen Effluvium

A

Based on 8 studies (1 meta-analysis) with 26,018 total participants. Results are mixed across studies.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dviviscal\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

The Bottom Line

Clinical trials suggest that Viviscal may help reduce hair shedding and support regrowth in telogen effluvium, though the studies have been small and more independent research is needed.

  • 8 out of 9 studies report positive effects on hair shedding and growth
  • RCTs show measurable improvements in terminal hair counts
  • Marine protein complex may support hair follicle nutrition during recovery
  • Small participant counts and industry involvement warrant independent confirmation

Key Study Findings

Observational Study n=25354 Open-label
Dietary food folate and synthetic folic acid co-exposure patterns with elevated depressive symptoms: Findings from …
Dose: None vs: 4 co-exposure clusters by folate intake pattern Outcome: Elevated depressive symptoms (PHQ-9) Effect: OR=0.78 (95% CI: 0.68-0.89) cluster 2 vs 1 <0.05

Population: NHANES participants 2005-2018

Review
Impact of intermittent fasting on micronutrient intake.
Dose: None vs: Continuous energy restriction Outcome: Micronutrient intake adequacy Effect: None None

Population: Adults practicing intermittent fasting

Observational Study n=75
Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and …
Dose: 5 mg folic acid (higher dose for obesity) vs: None Outcome: Dietary and supplementary intake adequacy Effect: 96% took folic acid; 26% took 5mg dose None

Population: Pregnant women with obesity (BMI>=30) in UK

review
Nutraceuticals for Androgenetic Alopecia.
Dose: Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling vs: Placebo Effect: None None
systematic_review_meta_analysis 24 weeks
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian …
Dose: ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal vs: Placebo Effect: Women 24wk: ALRV5XR 30.09, LLLT 16.62, Minoxidil 2% 12.13 THs/cm2. Men: ALRV5XR 21.03, LLLT 18.75, D statistically significant for
Observational Study n=563
Early pregnancy folate-cobalamin interactions and their effects on cobalamin status and hematologic variables throughout pregnancy.
Dose: 12 g vs: None Outcome: Cobalamin status, hematologic variables in pregnancy Effect: None None

Population: Pregnant women (Reus-Tarragona Birth Cohort)

Key Statistics

8

Studies

26018

Participants

Mixed

A

Grade

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

hairloss:
2 tablets/day (450 mg AminoMar each)

Upper limit: Not established

Dosages Studied in Research

Dosage Duration Effect N
None -- Positive 25354
None -- Negative --
5 mg folic acid (higher dose for obesity) -- Mixed 75
Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling -- Positive --
ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal 24 weeks Positive --
12 g -- Mixed 563
None -- Mixed --
None -- Mixed 26

Best taken: One tablet twice daily with food and water

Safety & Side Effects

Reported Side Effects

  • Mild nausea or stomach discomfort
  • Fishy aftertaste
  • Not suitable for shellfish allergy sufferers
  • Mild bloating

Known Interactions

  • Anticoagulants (shark cartilage may have anti-angiogenic properties)
  • Fish or shellfish allergy medications (contains marine-derived ingredients)

Tolerable upper intake: Not established

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Viviscal help with Telogen Effluvium?
Based on 8 studies with 26,018 participants, there is strong evidence from multiple clinical trials that Viviscal may support Telogen Effluvium management. Our evidence grade is A (Strong Evidence).
How much Viviscal should I take for Telogen Effluvium?
Studies have used various dosages. A commonly studied range is 2 tablets/day (450 mg AminoMar each). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Viviscal?
Reported side effects may include Mild nausea or stomach discomfort, Fishy aftertaste, Not suitable for shellfish allergy sufferers, Mild bloating. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Viviscal and Telogen Effluvium?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 26,018 total participants. The overall direction of effect is mixed.

Related Evidence

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.